# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-26-058649
Filing Date
2026-05-11
Accepted
2026-05-11 16:08:30
Documents
88
Period of Report
2026-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | ganx-20260331x10q.htm iXBRL | 10-Q | 1418439
2 | EX-31.1 | ganx-20260331xex31d1.htm | EX-31.1 | 11150
3 | EX-31.2 | ganx-20260331xex31d2.htm | EX-31.2 | 10316
4 | EX-32.1 | ganx-20260331xex32d1.htm | EX-32.1 | 11668
| Complete submission text file | 0001104659-26-058649.txt |  | 7512695

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | EX-101.SCH | ganx-20260331.xsd | EX-101.SCH | 57023
6 | EX-101.CAL | ganx-20260331_cal.xml | EX-101.CAL | 55846
7 | EX-101.DEF | ganx-20260331_def.xml | EX-101.DEF | 196298
8 | EX-101.LAB | ganx-20260331_lab.xml | EX-101.LAB | 503502
9 | EX-101.PRE | ganx-20260331_pre.xml | EX-101.PRE | 376381
92 | EXTRACTED XBRL INSTANCE DOCUMENT | ganx-20260331x10q_htm.xml | XML | 1304157

Mailing Address 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814
Business Address 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814 (301) 500-1556
Gain Therapeutics, Inc. (Filer) CIK: 0001819411 (see all company filings)

EIN.: 851726310 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40237 | Film No.: 26963231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)